Is VRSK a Buy or a Sell? The Bull and Bear Case (2026)
Last updated October 2026
Short answer
Both cases are real, which is why the question is contested. The bull case for Verisk Analytics (VRSK) rests on Recurring, subscription-heavy revenue: About 83% of Verisk's revenue is recurring and client retention exceeds 95%, which gives the model unusual visibility and resilience through insurance cycles. The bear case rests on the most cited risk is valuation versus growth: the stock trades at a premium multiple (~29x trailing and ~22x forward earnings as of October 2026) while organic growth sits in the mid-single digits, so any deceleration can pressure the multiple. Analysts covering it publish targets from $195.00 to $260.00 against a $190.90 price, so even the professionals disagree by 29% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.
Verisk Analytics traces back to 1971 as the Insurance Services Office (ISO), a non-profit ratings and data cooperative for property and casualty insurers, and it has since become a for-profit data-and-analytics company that sells almost exclusively into insurance. It operates through two main lines, Underwriting solutions (the larger piece, around $552 million in Q1 2026) and Claims solutions (around $231 million), providing risk-scoring data, policy-language standards, catastrophe and property analytics, fraud detection, and claims-estimating tools. Roughly 83% of revenue is recurring subscription-style, client retention runs above 95%, and the company generates ~$3.14 billion in trailing annual revenue at very high margins (~45% operating, ~28% net). The investment picture is one of quality and predictability rather than explosive growth. Verisk targets 6 to 8 percent annual revenue growth with steady margin expansion and returns capital through dividends and large buybacks (it launched a $1.5 billion accelerated repurchase in 2026 and raised its dividend about 11 percent). The debate centers on whether mid-single-digit organic growth (around 4.7% organic constant-currency in Q1 2026) justifies a premium multiple, and whether AI both threatens and augments its proprietary-data moat. Bulls see an entrenched insurance-data utility with pricing power; skeptics point to decelerating growth and a valuation that leaves little room for disappointment. The most recent quarter, Q2 2026, brought revenue of ~$806 million (up ~4.4% year over year) and adjusted EPS of $1.98 against a $1.93 consensus, the fourth straight quarter ahead of estimates. The share price has not followed: as of October 16, 2026 VRSK closed near $187.51, down ~15% year to date and ~18% over one year, well off a 52-week high near $239. Several brokers trimmed price targets in early October (Morgan Stanley to $215, BMO to $217, Deutsche Bank to $200) amid the debate over growth and AI. Q3 2026 results are due November 5, 2026, with consensus at ~$1.92 of EPS on ~$807 million of revenue.
The bull case: what would have to be true for $260.00
The most optimistic published target on VRSK is $260.00, +36.2% from the $190.90 price as of October 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.
1. Recurring, subscription-heavy revenue
About 83% of Verisk's revenue is recurring and client retention exceeds 95%, which gives the model unusual visibility and resilience through insurance cycles. Subscription revenue grew roughly 7% in Q1 2026, faster than the transactional book, and total revenue climbed sequentially from ~$783 million in Q1 to ~$806 million in Q2. This recurring base is the core of the bull thesis.
2. Entrenched position in insurance data
Verisk owns proprietary datasets, policy-language standards, and catastrophe and claims tools that insurers embed deeply into their workflows. Switching costs are high because the data feeds underwriting and pricing decisions across the P&C industry. That embeddedness supports steady price increases and high margins. Its catastrophe models also make Verisk a standard reference after storms: in October 2026 it estimated insured losses from Hurricane Isaias could reach $2 billion.
3. Margin expansion and capital returns
Management targets ongoing adjusted EBITDA margin expansion (about 60 basis points in Q1 2026) alongside 6 to 8 percent revenue growth. Verisk returns significant cash through a growing dividend (raised about 11% to roughly $2.00 annualized) and a $1.5 billion accelerated share repurchase. Buybacks and margin gains support per-share earnings growth above headline revenue growth.
4. AI and new-data monetization
Verisk is layering AI and machine learning onto its proprietary data to expand into new analytics use cases across underwriting and claims. Success here could re-accelerate organic growth and deepen the moat. It is also a two-sided factor, since AI could eventually let insurers build alternatives in-house.
The bear case: what would have to be true for $195.00
The most pessimistic published target is $195.00, +2.1% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Verisk Analytics is worth if the risks below bite instead of the drivers above.
The most cited risk is valuation versus growth: the stock trades at a premium multiple (~29x trailing and ~22x forward earnings as of October 2026) while organic growth sits in the mid-single digits, so any deceleration can pressure the multiple. That pressure is already visible in a ~15% year-to-date decline despite four straight earnings beats. Verisk's near-total concentration in insurance means an industry downturn, consolidation among carriers, or pricing pushback would hit it broadly. Free cash flow softened in Q1 2026 (down roughly 17% year over year), and trailing free cash flow now stands near $1.06 billion. Leverage has also risen with buybacks, to ~$4.6 billion of debt against ~$0.55 billion of cash. Competition from Fair Isaac, LexisNexis Risk Solutions, CoreLogic, and Moody's RMS in catastrophe modeling could erode share in specific niches. Finally, AI is a double-edged sword that could either widen or, over time, commoditize parts of its data moat.
The bear case deserves the same attention as the bull case, and usually gets less. If you are holding VRSK already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.
Where analysts land on VRSK
17 analysts cover VRSK, with an average target of $227.94 (+19.4% against $190.90) and a split of 11 buy, 8 hold, 0 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the VRSK forecast and price target page.
How is VRSK valued? (as of October 2026)
Snapshot for VRSK as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.
- Revenue (TTM): ~$3.14B, up ~4.4% year over year in Q2 2026
- Margins (TTM): ~70% gross, ~45% operating, ~28% net
- Net income (TTM): ~$886M; trailing EPS ~$6.51
- Trailing P/E: ~29x
- Forward P/E: ~22x
- Dividend: ~$2.00 per share, ~1.1% yield
- Market cap: ~$24.6B at ~$187.51 per share
- 2026 consensus: ~$3.22B revenue, ~$7.70 EPS
As of October 16, 2026, Verisk traded near $187.51 with a market cap of about $24.6 billion, an EV/EBITDA near 19 and a ~1.1% dividend yield. The forward multiple has eased to ~22x as the shares fell ~15% this year while earnings estimates held, with analysts looking for EPS of ~$7.70 in 2026 and ~$8.70 in 2027. The premium still reflects the recurring-revenue quality, and modest top-line growth is why some observers flag valuation risk.
How do you decide if VRSK is a buy?
Rather than asking whether VRSK is a buy in the abstract, it tends to help to answer four questions:
- Thesis: do you believe the bull case above, and is it still true today?
- Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
- Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
- Overlap: check whether you already hold VRSK indirectly through an index or sector ETF before adding more.
What would change your mind on VRSK
Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.
- Bull case breaks if: Recurring, subscription-heavy revenue stalls in the reported numbers rather than in the narrative around them.
- Bear case breaks if: the most cited risk is valuation versus growth: the stock trades at a premium multiple (~29x trailing and ~22x forward earnings as of October 2026) while organic growth sits in the mid-single digits, so any deceleration can pressure the multiple fails to materialise over several reporting periods while the drivers keep compounding.
- Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.
For the full picture, see the VRSK stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about VRSK against your real portfolio and see your actual exposure before deciding.
Investing in Verisk Analytics with AI
Connect the broker you already use and ask Walnut's AI how VRSK fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.
FAQ
Is VRSK a good stock to buy right now?
+
That depends on which case you find more convincing, and both are on this page. The bull case rests on Recurring, subscription-heavy revenue, with revenue (ttm) at ~$3.14B, up ~4.4% year over year in Q2 2026. The bear case rests on the most cited risk is valuation versus growth: the stock trades at a premium multiple (~29x trailing and ~22x forward earnings as of October 2026) while organic growth sits in the mid-single digits, so any deceleration can pressure the multiple. Analysts covering it are spread from $195.00 to $260.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.
Should I sell VRSK?
+
Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The most cited risk is valuation versus growth: the stock trades at a premium multiple (~29x trailing and ~22x forward earnings as of October 2026) while organic growth sits in the mid-single digits, so any deceleration can pressure the multiple. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $195.00, +2.1% from the $190.90 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.
What is the bull case for VRSK?
+
Recurring, subscription-heavy revenue. About 83% of Verisk's revenue is recurring and client retention exceeds 95%, which gives the model unusual visibility and resilience through insurance cycles. The most optimistic analyst target on VRSK is $260.00, +36.2% from the $190.90 price. That figure is only reachable if this thesis works close to its best case.
What is the bear case for VRSK?
+
The most cited risk is valuation versus growth: the stock trades at a premium multiple (~29x trailing and ~22x forward earnings as of October 2026) while organic growth sits in the mid-single digits, so any deceleration can pressure the multiple. That pressure is already visible in a ~15% year-to-date decline despite four straight earnings beats. Verisk's near-total concentration in insurance means an industry downturn, consolidation among carriers, or pricing pushback would hit it broadly. Free cash flow softened in Q1 2026 (down roughly 17% year over year), and trailing free cash flow now stands near $1.06 billion. Leverage has also risen with buybacks, to ~$4.6 billion of debt against ~$0.55 billion of cash. Competition from Fair Isaac, LexisNexis Risk Solutions, CoreLogic, and Moody's RMS in catastrophe modeling could erode share in specific niches. Finally, AI is a double-edged sword that could either widen or, over time, commoditize parts of its data moat. The most pessimistic published target is $195.00, +2.1% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.
What does Verisk Analytics do?
+
Verisk Analytics traces back to 1971 as the Insurance Services Office (ISO), a non-profit ratings and data cooperative for property and casualty insurers, and it has since become a
What would have to change for VRSK to stop being worth holding?
+
Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Recurring, subscription-heavy revenue) stalling in the reported numbers rather than in the narrative, the risk above (the most cited risk is valuation versus growth: the stock trades at a premium multiple (~29x trailing and ~22x forward earnings as of October 2026) while organic growth sits in the mid-single digits, so any deceleration can pressure the multiple) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.
What does Verisk Analytics do?
+
Verisk sells data, analytics, and software to the insurance industry, mainly property and casualty insurers. Its two core segments are Underwriting solutions (risk scoring, policy standards, catastrophe and property data) and Claims solutions (fraud detection and claims-estimating tools).
Is VRSK a stable or a high-growth stock?
+
It is generally viewed as a stable, quality compounder rather than a high-growth name. Verisk targets 6 to 8 percent annual revenue growth with high recurring revenue (about 83%) and margin expansion, and organic growth ran around 4.7% in Q1 2026, with total revenue up ~4.4% in Q2 2026.
How does Verisk make money?
+
The bulk of revenue is recurring, subscription-style access to proprietary datasets and analytics that insurers embed into underwriting, pricing, and claims workflows. Client retention exceeds 95%, and subscription revenue grew about 7% in Q1 2026.
Walnut is informational, not investment advice, and gives no verdict on VRSK. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.